4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-109410
President and CEO sold 11,747 shares at an average $24.11 ($283,223)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Harris Todd · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-23 | Sale : show line 1 in the form 10b5-1 | −10,092 | $24.13 | $243,477 | 1,479,528 | D |
| 2024-09-24 | Sale : show line 2 in the form 10b5-1 | −1,055 | $24.02 | $25,341 | 1,478,473 | D |
| 2024-09-25 | Sale : show line 3 in the form 10b5-1 | −600 | $24.01 | $14,406 | 1,477,873 | D |
| Open-market sales · 11,747 sh · avg $24.11 · $283,223 | ||||||
Loading xslF345X05/ownership.xml…